It began operations in the Philippines in 1989 and has since established a strong presence in the local market.
Medtecs International, on Jan 14, signed a letter of intent (LOI) with Enimmune Corporation, where both companies seek to leverage on each other’s strengths to explore opportunities to market and promote Enimmune’s “Speedy Covid-19 Ag Rapid Test” in the Philippines.
Enimmune is a joint venture vaccine development and marketing company that is jointly established by Adimmune Corporation and other venture capital investors.
